摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

suberoyl ethylcarbonate | 41246-58-6

中文名称
——
中文别名
——
英文名称
suberoyl ethylcarbonate
英文别名
Korksaeure-bis--ester;Korksaeure-bis-(aethoxycarbonyl)-ester
suberoyl ethylcarbonate化学式
CAS
41246-58-6
化学式
C14H22O8
mdl
——
分子量
318.324
InChiKey
HZQKJFKAJFJTTL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.73
  • 重原子数:
    22.0
  • 可旋转键数:
    9.0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    105.2
  • 氢给体数:
    0.0
  • 氢受体数:
    8.0

反应信息

  • 作为反应物:
    描述:
    suberoyl ethylcarbonate 在 sodium tetrahydroborate 、 3 A molecular sieve 、 氢溴酸三氟乙酸 作用下, 以 1,4-二氧六环甲醇溶剂黄146 为溶剂, 反应 20.5h, 生成 N1,N8-di(4-{[(2-methoxybenzyl)amino]methyl}benzyl)octanediamine
    参考文献:
    名称:
    Design, Synthesis, and Biological Evaluation of Symmetrically and Unsymmetrically Substituted Methoctramine-Related Polyamines as Muscular Nicotinic Receptor Noncompetitive Antagonists
    摘要:
    The universal template approach to drug design foresees that a polyamine can be modified in such a way to recognize any neurotransmitter receptor. Thus, hybrids of polymethylene tetraamines and philanthotoxins, exemplified by methoctramine (1) and PhTX-343 (2), respectively, were synthesized to produce novel inhibitors of muscular nicotinic acetylcholine receptors. Polyamines 3-25 were synthesized and their biological profiles were evaluated at frog rectus abdominis muscle nicotinic receptors and guinea pig left atria (M-2) and ileum longitudinal muscle (M-3) muscarinic acetylcholine receptors. All of the compounds, like prototypes 1 and 2, were noncompetitive antagonists of nicotinic receptors while being, like 1, competitive antagonists at,muscarinic M-2 and M-3 receptor subtypes. interestingly, polyamines bearing a low number of methylenes between the nitrogen atoms, as in 3, 6, and 7, displayed a biological profile similar to that of 2: a noncompetitive antagonism at nicotinic receptors in the 7-25 mu M range while not showing any antagonism for muscarinic receptors up to 10 mu M. increasing the number of methylenes separating these nitrogen atoms in methoctramine related tetraamines resulted in a significant improvement; in potency at nicotinic receptors. The most potent tetraamine was 19, bearing a 12 methylene spacer between the nitrogen atoms, which was 12-fold and 250-fold more potent than prototypes 1 and 2, respectively. Tetraamines 9-11, bearing a rather rigid spacer between the nitrogen atoms instead of the very flexible polymethylene chain, displayed a profile similar to that of 1 at nicotinic receptors, whereas a significant decrease in potency was observed at muscarinic M-2 receptors. This finding may have relevance in understanding the mode of interaction with these receptors. Similarly, the constrained analogue 12 of methoctramine showed a decrease in potency at nicotinic and muscarinic M-2 receptors, revealing that the tricyclic system, which incorporates the 2-methoxybenzylamine moiety of 1, does not represent a good pharmacophore for activity at these sites. A most intriguing finding was the observation that the photolabile tetraamine 22 was more potent than methoctramine at nicotinic receptors and, what is more important, it inhibited a closed stale of the receptor.
    DOI:
    10.1021/jm991110n
  • 作为产物:
    描述:
    辛二酸氯甲酸乙酯三乙胺 作用下, 以 四氢呋喃 为溶剂, 反应 0.5h, 生成 suberoyl ethylcarbonate
    参考文献:
    名称:
    一系列双插双蒽环类化合物的合成与表征
    摘要:
    据报道,双-柔红霉素衍生物(5a - g)的合成已被证明可以作为DNA的双插层剂,并且还具有缓慢的DNA分解动力学。
    DOI:
    10.1039/c39860000659
点击查看最新优质反应信息

文献信息

  • Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen–SAHA hybrids and related species
    作者:José de Jesús Cázares Marinero、Marion Lapierre、Vincent Cavaillès、Rénette Saint-Fort、Anne Vessières、Siden Top、Gérard Jaouen
    DOI:10.1039/c3dt51917a
    日期:——
    Chemotherapeutic agents combining several active groups within a single molecule can modulate multiple cellular pathways and, thus, exhibit higher efficacy than single-target drugs. In this study, six new hybrid compounds combining tamoxifen (TAM) or ferrocifen (FcTAM) structural motifs with suberoylanilide hydroxamic acid (SAHA) were synthesised and evaluated. Antiproliferative activity was first explored in cancer cell lines. Combining FcTAM and SAHA structural motifs to form the unprecedented FcTAM–SAHA hybrid molecule led to an increased cytotoxicity (IC50 = 0.7 μM) in triple-negative MDA-MB-231 breast cancer cells when compared to FcTAM or SAHA alone (IC50 = 2.6 μM and 3.6 μM, respectively), while the organic hybrid analogue TAM–SAHA was far less cytotoxic (IC50 = 8.6 μM). In hormone-dependent MCF-7 breast cancer cells, FcTAM–SAHA was more active (IC50 = 2.0 μM) than FcTAM (IC50 = 4.4 μM) and TAM–SAHA (IC50 > 10 μM), but less toxic than SAHA (IC50 = 1.0 μM). Surprisingly, FcTAM–PSA, an N1-phenylsuberamide derivative, also possessed strong antiproliferative activity (IC50 = 0.5 μM and 1.8 μM in MDA-MB-231 and MCF-7 cells, respectively). Subsequent biochemical studies indicate that estrogen receptor alpha (ERα) and histone deacetylases (HDAC) are not the main targets of the hybrid compounds for their antiproliferative effect. Interestingly, both organometallic compounds were able to induce p21waf1/cip1 gene expression in MCF-7 breast cancer cells in accordance with their antiproliferative activity.
    将多个活性基团结合于单一分子中的化疗药物能够调控多条细胞信号通路,因此其疗效高于单一靶点药物。在本研究中,我们合成并评估了6种新型混合化合物,它们结合了他莫昔芬(TAM)或西他莫(FcTAM)结构基团与辛二酰苯胺异羟酸(SAHA)。首先在癌细胞系中探索它们的抗增殖活性。将FcTAM与SAHA结构基团结合起来形成前所未有的FcTAM-SAHA混合分子,与单独的FcTAM或SAHA相比(分别为IC50 = 2.6 μM和3.6 μM),在三阴性乳腺癌细胞MDA-MB-231中显示出增加的细胞毒性(IC50 = 0.7 μM),而有机混合类似物TAM-SAHA的细胞毒性则低得多(IC50 = 8.6 μM)。在激素依赖性乳腺癌细胞MCF-7中,FcTAM-SAHA的活性比FcTAM(IC50 = 4.4 μM)和TAM-SAHA(IC50 > 10 μM)更高(IC50 = 2.0 μM),但毒性比SAHA(IC50 = 1.0 μM)低。令人惊讶的是,N1-苯基辛二酰胺衍生物FcTAM-PSA也显示出强大的抗增殖活性(在MDA-MB-231和MCF-7细胞中分别为IC50 = 0.5 μM和1.8 μM)。后续的生化研究表明,雌激素受体α(ERα)和组蛋白去乙酰化酶(HDAC)并不是这些混合化合物抗增殖作用的主要靶点。有趣的是,这两种有机属化合物都能根据其抗增殖活性诱导MCF-7乳腺癌细胞中的p21waf1/cip1基因表达。
  • Proximity Effects in the Decomposition of Mixed Dicarboxylic—Carbonic Anhydrides
    作者:Thomas B. Windholz、John B. Clements
    DOI:10.1021/jo01033a055
    日期:1964.10
  • Minarini; Budriesi; Chiarini, Il Farmaco, 1991, vol. 46, # 10, p. 1167 - 1178
    作者:Minarini、Budriesi、Chiarini、Melchiorre、Tumiatti
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸